EGFR and lung adenocarcinoma: Here, we screened 230 Chinese patient samples of lung SCC and reported the rarity of two most ubiquitous mutations in KRAS and EGFR seen in lung adenocarcinoma, while PIK3CA mutations were relatively high when compared with lung adenocarcinoma.